4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040561
EVP, Chief Sci. & Tech Officer sold 15,126 shares at an average $1.65 ($24,997)
From the SEC's structured data for this filing
Trades in this filing
Nguyen AnhCo · EVP, Chief Sci. & Tech Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-16 | Sale : show line 1 in the form | −5,849 | $1.65 | $9,663 | 295,276 | D |
| 2023-08-16 | Sale : show line 2 in the form | −9,277 | $1.65 | $15,335 | 285,999 | D |
| Open-market sales · 15,126 sh · avg $1.65 · $24,997 | ||||||
Loading xslF345X05/form4.xml…